{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T02:46:15Z","timestamp":1768013175426,"version":"3.49.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,10,13]]},"DOI":"10.7759\/cureus.10929","type":"journal-article","created":{"date-parts":[[2020,10,13]],"date-time":"2020-10-13T16:50:18Z","timestamp":1602607818000},"source":"Crossref","is-referenced-by-count":4,"title":["A Common Drug With a Dangerous Side Effect: Acute Rhabdomyolysis Caused by the Synergistic Effect of Isotretinoin and Exercise in an Adolescent"],"prefix":"10.7759","author":[{"given":"Kingshuk","family":"Dasgupta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Lim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hannah","family":"Reedstorm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/s0190-9622(83)70176-3","article-title":"Isotretinoin treatment of acne and related disorders: an update","volume":"9","author":"Shalita AR","year":"1983","unstructured":"Shalita AR, Cunningham WJ, Leyden JJ, Pochi PE, Strauss JS. Isotretinoin treatment of acne and related disorders: an update. J Am Acad Dermatol. 1983, 9:629-638. 10.1016\/s0190-9622(83)70176-3","journal-title":"J Am Acad Dermatol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1177\/106002808301700502","article-title":"Isotretinoin in severe, recalcitrant cystic acne: a review","volume":"17","author":"Rumsfield JA","year":"1983","unstructured":"Rumsfield JA, West DP, Tse CS, Eaton ML, Robinson LA. Isotretinoin in severe, recalcitrant cystic acne: a review. Drug Intell Clin Pharm. 1983, 17:329-333. 10.1177\/106002808301700502","journal-title":"Drug Intell Clin Pharm"},{"key":"ref3","article-title":"Isotretinoin (Accutane): therapy for acne in adolescents","volume":"1","author":"Abel EA","year":"1990","unstructured":"Abel EA. Isotretinoin (Accutane): therapy for acne in adolescents. Adolesc Med. 1990, 1:315-324.","journal-title":"Adolesc Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-4362.1999.00651.x","article-title":"Treatment outcome of acne vulgaris with oral isotretinoin in 89 patients","volume":"38","author":"Ng PP","year":"1999","unstructured":"Ng PP, Goh CL. Treatment outcome of acne vulgaris with oral isotretinoin in 89 patients. Int J Dermatol. 1999, 38:213-216. 10.1046\/j.1365-4362.1999.00651.x","journal-title":"Int J Dermatol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009435.pub2","article-title":"Oral isotretinoin for acne","volume":"11","author":"Costa CS","year":"2018","unstructured":"Costa CS, Bagatin E, Martimbianco ALC, da Silva EM, Lucio MM, Magin P, Riera R. Oral isotretinoin for acne. Cochrane Database Syst Rev. 2018, 11:009435. 10.1002\/14651858.CD009435.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(84)80116-4","article-title":"Elevated creatine phosphokinase with isotretinoin","volume":"10","author":"McBurney EI","year":"1984","unstructured":"McBurney EI, Rosen DA. Elevated creatine phosphokinase with isotretinoin. J Am Acad Dermatol. 1984, 10: 528-529. 10.1016\/S0190-9622(84)80116-4","journal-title":"J Am Acad Dermatol"},{"key":"ref7","article-title":"Muscular damage during isotretinoin treatment [Article in French]","volume":"125","author":"Heudes AM","year":"1998","unstructured":"Heudes AM, Laroche L. Muscular damage during isotretinoin treatment [Article in French]. Ann Dermatol Venereol. 1998, 125:94-97.","journal-title":"Ann Dermatol Venereol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1159\/000247987","article-title":"Creatine kinase values during isotretinoin treatment","volume":"180","author":"Bettoli V","year":"1990","unstructured":"Bettoli V, Tosti A, Capobianco C, Varotti C. Creatine kinase values during isotretinoin treatment. Dermatologica. 1990, 180:54-55. 10.1159\/000247987","journal-title":"Dermatologica"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/9.6.637","article-title":"Relationship between elevated creatine phosphokinase and the clinical spectrum of rhabdomyolysis","volume":"9","author":"Veenstra J","year":"1994","unstructured":"Veenstra J, Smit WM, Krediet RT, Arisz L. Relationship between elevated creatine phosphokinase and the clinical spectrum of rhabdomyolysis. Nephrol Dial Transplant. 1994, 9:637-641. 10.1093\/ndt\/9.6.637","journal-title":"Nephrol Dial Transplant"},{"key":"ref10","article-title":"Isotretinoin induced rhabdomyolysis? A case report","volume":"5","author":"Trauner MA","year":"1999","unstructured":"Trauner MA, Ruben BS. Isotretinoin induced rhabdomyolysis? A case report. Dermatol Online J. 1999, 5:2.","journal-title":"Dermatol Online J"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1080\/000155501317140070","article-title":"Clinical significance of markedly elevated serum creatine kinase levels in patients with acne on isotretinoin","volume":"81","author":"Landau M","year":"2001","unstructured":"Landau M, Mesterman R, Ophir J, Mevorah B, Alcalay J, Harel A, Nevo Y. Clinical significance of markedly elevated serum creatine kinase levels in patients with acne on isotretinoin. Acta Derm Venereol. 2001, 81:350-352. 10.1080\/000155501317140070","journal-title":"Acta Derm Venereol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-4362.2003.01917.x","article-title":"Acute rhabdomyolysis and myoglobinuria associated with isotretinoin treatment","volume":"42","author":"Guttman-Yassky E","year":"2003","unstructured":"Guttman-Yassky E, Hayek T, Muchnik L, Bergman R. Acute rhabdomyolysis and myoglobinuria associated with isotretinoin treatment. Int J Dermatol. 2003, 42:499-500. 10.1046\/j.1365-4362.2003.01917.x","journal-title":"Int J Dermatol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s00414-012-0750-2","article-title":"Severe generalised rhabdomyolysis with fatal outcome associated with isotretinoin","volume":"126","author":"Hartung B","year":"2012","unstructured":"Hartung B, Merk HF, Huckenbeck W, Daldrup T, Neuen-Jacob E, Ritz-Timme S. Severe generalised rhabdomyolysis with fatal outcome associated with isotretinoin. Int J Legal Med. 2012, 126:953-956. 10.1007\/s00414-012-0750-2","journal-title":"Int J Legal Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1186\/cc2978","article-title":"Bench-to-bedside review: rhabdomyolysis - an overview for clinicians","volume":"9","author":"Huerta-Alardin AL","year":"2005","unstructured":"Huerta-Alardin AL, Varon J, Marik PE. Bench-to-bedside review: rhabdomyolysis - an overview for clinicians. Crit Care. 2005, 9:158-169. 10.1186\/cc2978","journal-title":"Crit Care"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jflm.2020.101941","article-title":"Rhabdomyolysis associated acute renal failure - report of two fatal cases and a brief review of literature","volume":"71","author":"Das S","year":"2020","unstructured":"Das S, Hanuman SB, Mylapalli JL. Rhabdomyolysis associated acute renal failure - report of two fatal cases and a brief review of literature. J Forensic Leg Med. 2020, 71:101941. 10.1016\/j.jflm.2020.101941","journal-title":"J Forensic Leg Med"},{"key":"ref16","unstructured":"iPLEDGE. (2020). Accessed. September 10, 2020: https:\/\/www.ipledgeprogram.com\/iPledgeUI\/aboutProgram.u."},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.2165\/11319020-000000000-00000","article-title":"Neuromuscular adverse effects associated with systemic retinoid dermatotherapy. Monitoring and treatment algorithm for clinicians","volume":"33","author":"Chroni E","year":"2010","unstructured":"Chroni E, Monastirli A, Tsambaos D. Neuromuscular adverse effects associated with systemic retinoid dermatotherapy. Monitoring and treatment algorithm for clinicians. Drug Saf. 2010, 33:25-34. 10.2165\/11319020-000000000-00000","journal-title":"Drug Saf"},{"key":"ref18","article-title":"Isotretinoin and exercise: can the two walk together? [Article in Hebrew]","volume":"153","author":"Dalal A","year":"2014","unstructured":"Dalal A, Ben-Barak S, Zlotogorski A, Constantini N. Isotretinoin and exercise: can the two walk together? [Article in Hebrew]. Harefuah. 2014, 153:104-108.","journal-title":"Harefuah"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1990.tb04418.x","article-title":"Isotretinoin, creatine kinase and exercise","volume":"123","author":"Tillman DM","year":"1990","unstructured":"Tillman DM, White SI, Aitchison TC. Isotretinoin, creatine kinase and exercise. Br J Dermatol. 1990, 123:22-23. 10.1111\/j.1365-2133.1990.tb04418.x","journal-title":"Br J Dermatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/35782-a-common-drug-with-a-dangerous-side-effect-acute-rhabdomyolysis-caused-by-the-synergistic-effect-of-isotretinoin-and-exercise-in-an-adolescent","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:18:39Z","timestamp":1707506319000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/35782-a-common-drug-with-a-dangerous-side-effect-acute-rhabdomyolysis-caused-by-the-synergistic-effect-of-isotretinoin-and-exercise-in-an-adolescent"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,13]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.10929","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10,13]]}}}